23andMe, the consumer DNA testing company, has been in touch with a SPAC founded by Richard Branson about a potential merger, Bloomberg reported. Founded in 2006, the company has raised almost $800 million from investors including GV, G Squared and Sequoia. It was valued at $2.5 billion after a funding round in 2018, according to PitchBook data.